Monoclonal gammopathy of thrombotic/thrombocytopenic significance
Blood
.
2023 Apr 6;141(14):1772-1776.
doi: 10.1182/blood.2022018797.
Authors
Adam J Kanack
1
,
Jordan K Schaefer
2
,
Meera Sridharan
3
,
Noah P Splinter
1
,
Mindy C Kohlhagen
1
,
Bandana Singh
1
,
Silvana B De Lorenzo
1
,
Emily E Mauch
1
,
Maen A Hussein
4
,
Marwan Shaikh
5
,
Shaji Kumar
3
,
Renren Wen
6
,
Demin Wang
6
,
David Murray
1
,
Anand Padmanabhan
1
Affiliations
1
Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN.
2
Department of Medicine, University of Michigan, Ann Arbor, MI.
3
Department of Medicine, Mayo Clinic, Rochester, MN.
4
Florida Cancer Specialists, Orlando, FL.
5
Department of Medicine, Mayo Clinic, Jacksonville, FL.
6
Department of Microbiology and Immunology, Versiti Blood Research Institute and Medical College of Wisconsin, Milwaukee, WI.
PMID:
36626584
PMCID:
PMC10113173
DOI:
10.1182/blood.2022018797
No abstract available
Publication types
Research Support, N.I.H., Extramural
MeSH terms
Humans
Monoclonal Gammopathy of Undetermined Significance* / complications
Paraproteinemias* / complications
Thrombosis* / etiology
Grants and funding
R01 HL130724/HL/NHLBI NIH HHS/United States
R01 HL148120/HL/NHLBI NIH HHS/United States
R01 HL158932/HL/NHLBI NIH HHS/United States
R01 HL161127/HL/NHLBI NIH HHS/United States